Triple
T2334607
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Cambridge Stem Cell Institute |
E44280
|
entity |
| Predicate | collaboratesWith |
P37
|
FINISHED |
| Object |
Wellcome Sanger Institute
The Wellcome Sanger Institute is a leading British genomics research center renowned for its pivotal role in the Human Genome Project and large-scale DNA sequencing initiatives.
|
E256950
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Wellcome Sanger Institute | Statement: [Cambridge Stem Cell Institute, collaboratesWith, Wellcome Sanger Institute]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Wellcome Sanger Institute Context triple: [Cambridge Stem Cell Institute, collaboratesWith, Wellcome Sanger Institute]
-
A.
Babraham Research Campus
Babraham Research Campus is a major life sciences research and innovation hub near Cambridge, England, focused on bioscience, biotechnology, and academic–industry collaboration.
-
B.
Cambridge Stem Cell Institute
The Cambridge Stem Cell Institute is a leading research center at the University of Cambridge dedicated to understanding stem cell biology and translating this knowledge into new treatments for human disease.
-
C.
Broad Institute of MIT and Harvard
The Broad Institute of MIT and Harvard is a leading biomedical and genomic research center known for large-scale collaborative projects that advance understanding of human disease and inform new therapies.
-
D.
Cambridge Clinical Research Centre
Cambridge Clinical Research Centre is a major medical research facility based at the Cambridge Biomedical Campus, supporting advanced clinical studies and translational medicine.
-
E.
Wellcome–MRC Institute of Metabolic Science
The Wellcome–MRC Institute of Metabolic Science is a leading research center at the University of Cambridge focused on understanding and treating metabolic diseases such as obesity and diabetes.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Wellcome Sanger Institute Triple: [Cambridge Stem Cell Institute, collaboratesWith, Wellcome Sanger Institute]
Generated description
The Wellcome Sanger Institute is a leading British genomics research center renowned for its pivotal role in the Human Genome Project and large-scale DNA sequencing initiatives.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Wellcome Sanger Institute Target entity description: The Wellcome Sanger Institute is a leading British genomics research center renowned for its pivotal role in the Human Genome Project and large-scale DNA sequencing initiatives.
-
A.
Babraham Research Campus
Babraham Research Campus is a major life sciences research and innovation hub near Cambridge, England, focused on bioscience, biotechnology, and academic–industry collaboration.
-
B.
Cambridge Stem Cell Institute
The Cambridge Stem Cell Institute is a leading research center at the University of Cambridge dedicated to understanding stem cell biology and translating this knowledge into new treatments for human disease.
-
C.
Broad Institute of MIT and Harvard
The Broad Institute of MIT and Harvard is a leading biomedical and genomic research center known for large-scale collaborative projects that advance understanding of human disease and inform new therapies.
-
D.
Cambridge Clinical Research Centre
Cambridge Clinical Research Centre is a major medical research facility based at the Cambridge Biomedical Campus, supporting advanced clinical studies and translational medicine.
-
E.
Wellcome–MRC Institute of Metabolic Science
The Wellcome–MRC Institute of Metabolic Science is a leading research center at the University of Cambridge focused on understanding and treating metabolic diseases such as obesity and diabetes.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a889132b488190bbb43ad4780ddd92 |
completed | March 4, 2026, 7:33 p.m. |
| NER | Named-entity recognition | batch_69abc687362c8190a55b3d6cb1580d56 |
completed | March 7, 2026, 6:32 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69ae897bf59c8190bc0ac8a4f3841832 |
completed | March 9, 2026, 8:49 a.m. |
| NEDg | Description generation | batch_69ae8aceea58819098a98f7ad5818ac6 |
completed | March 9, 2026, 8:54 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69ae8b6c553481908b2b7b1f880b814d |
completed | March 9, 2026, 8:57 a.m. |
Created at: March 4, 2026, 7:51 p.m.